Arecor Therapeutics PLC

AREC

Company Profile

  • Business description

    Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing medicines to market through the enhancement of existing therapeutic products. By applying an proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, Germany, Italy, the Rest of Europe, the USA, and India, out of which the majority is from the UK.

  • Contact

    Chesterford Research Park
    Little Chesterford
    Saffron WaldenCB10 1XL
    GBR

    T: +44 1223426060

    E: [email protected]

    https://www.arecor.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    44

Stocks News & Analysis

stocks

Fair value downgraded for ASX heavyweight

Our capital allocation rating was also lowered due to balance sheet weakness.
stocks

ChatGPT enters the retail space and one company surges

Investors cheer the ability to purchase directly from ChatGPT.
stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,136.6015.100.17%
CAC 407,966.9571.010.90%
DAX 4024,113.62232.900.98%
Dow JONES (US)46,375.3622.53-0.05%
FTSE 1009,446.4396.001.03%
HKSE26,855.56232.680.87%
NASDAQ22,694.5434.530.15%
Nikkei 22544,550.85381.78-0.85%
NZX 50 Index13,433.99141.631.07%
S&P 5006,692.033.570.05%
S&P/ASX 2008,845.7012.300.14%
SSE Composite Index3,882.7820.250.52%

Market Movers